John Spencer
Chief Financial OfficerMr. John Spencer is Chief Financial Officer of Oragenics, Inc. from July 1, 2026. He joined the Company in April 2025 as Senior Controller and has led the Company’s finance and accounting organization, including SEC reporting, financial planning and analysis, treasury, budgeting, internal controls, audit coordination and capital markets support. From March 2022 through April 2025, Mr. Spencer operated a fractional chief financial officer and financial consulting practice, providing financial leadership to publicly traded and privately held companies across multiple industries, including healthcare, sports and entertainment and professional services. His responsibilities included SEC reporting, financial planning and analysis, budgeting and forecasting, treasury, internal controls, acquisition accounting, capital planning, operational finance and strategic financial leadership. Previously, Mr. Spencer served as Vice President of Finance at Trxade Health, Inc., a publicly traded healthcare technology company, where he was responsible for SEC reporting, financial planning and analysis, internal controls, acquisition accounting, finance operations and strategic finance initiatives. Mr. Spencer began his career with PricewaterhouseCoopers LLP, where he provided audit and tax services to publicly traded and privately held companies. Mr. Spencer is a Certified Public Accountant in the State of Florida and received both a Master of Accountancy and a Bachelor of Science in Accounting from the University of South Florida.
Positions
- Company NameOragenics, Inc.Stock CodeOGENPositionChief Financial OfficerColleagues
- JHJanet HuffmanCEO, President, Secretary & Treasurer
- CLCharles L. PopeIndependent Chairman of the Board
- JPJames P. KellyChief Medical Officer
- WFWilliam Franklin PeacockChief Clinical Officer
- FWFrederick W. TellingIndependent Director
- AWAlan W. DuntonIndependent Director
- RCRobert Clayton KoskiIndependent Director
- JPJohn P. GandolfoIndependent Director
